Barriers to Equitable Pediatric Oncologic Care in the United States

Meaghan Mormann1, Ayah El-Khatib2, Lindsay J Blazin3

  • 1University of Chicago Comer Children's Hospital.

Pediatric Annals
|December 2, 2025
PubMed

Insights

Pediatric cancer survival is improving, but racial, ethnic, and socioeconomic disparities in the US hinder equitable benefits. Addressing these health inequities requires systemic changes for better child cancer outcomes.

Area of Science:

  • Pediatric Oncology
  • Health Disparities Research
  • Health Equity

Background:

  • Pediatric cancer survival rates have improved.
  • Significant health disparities persist for children and adolescents in the United States.
  • These inequities prevent equitable benefit from medical advancements.

Purpose of the Study:

  • To examine health inequities in pediatric cancer diagnoses.
  • To investigate factors including race, ethnicity, language, socioeconomic status, and geography.
  • To understand the impact of these factors on diagnosis, treatment, and outcomes.

Main Methods:

  • A literature search was conducted.
  • 33 articles were identified and reviewed.
  • Analysis focused on intersecting factors affecting pediatric cancer care.

Main Results:

  • Black and Hispanic patients experience poorer survival rates.
  • Language barriers correlate with delayed care and higher mortality.
  • Low socioeconomic status and lack of insurance lead to late diagnoses and nonadherence.
  • Rural and marginalized urban residents face increased mortality.
  • Disparities in clinical trial enrollment limit access to novel therapies.

Conclusions:

  • Systemic reform is essential to address pediatric cancer disparities.
  • Culturally informed care and inclusive research practices are needed.
  • Ensuring equitable outcomes for all children requires targeted interventions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
244
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
4.5K